| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $107.5M | — | -2.3% |
| Cost of Revenue | $12.0M | — | +2.7% |
| Gross Profit | $95.6M | — | -2.9% |
| R&D Expense | $26.1M | — | -21.6% |
| SG&A Expense | $16.0M | — | -12.6% |
| Operating Income | -$1.5M | — | +86.7% |
| Pre-tax Income | -$5.6M | — | +59.3% |
| Income Tax | -$836K | — | +4.5% |
| Net Income | -$4.7M | — | +63.1% |
| EPS (Basic) | -$0.06 | — | +53.8% |
| EPS (Diluted) | -$0.06 | — | +53.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $251.0M | +33.5% | +13.5% |
| Accounts Receivable | $23.9M | -6.9% | -3.7% |
| Current Assets | $431.5M | -3.9% | -14.9% |
| Total Assets | $551.2M | -3.2% | -12.4% |
| Current Liabilities | $59.3M | -16.3% | -17.9% |
| Long-term Debt | $545.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.5M | — | +64.8% |
| Capital Expenditures | $140K | — | -52.5% |
| Investing Cash Flow | $76.7M | — | +96.5% |
| Financing Cash Flow | -$10.3M | — | +61.1% |
| Free Cash Flow | -$3.6M | — | +64.5% |
| +0.2% |
| Total Liabilities | $635.0M | -1.8% | -0.9% |
| Stockholders' Equity | -$83.8M | -8.5% | -639.6% |